Yuichi Shiraishi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 220 publications

Personalized reference genome-based pipeline reveals comprehensive haplotype-resolved views of cancer genomes.

Personalized reference genome-based pipeline reveals comprehensive haplotype-resolved views of cancer genomes.

Journal: bioRxiv : the preprint server for biology
Published: July 17, 2026

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

Journal: NPJ precision oncology
Published: February 14, 2026

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trial.

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trial.

Journal: Blood advances
Published: February 04, 2026

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: phase 2 of NCCH1903/ATTACK trial.

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: phase 2 of NCCH1903/ATTACK trial.

Journal: Blood advances
Published: February 04, 2026

Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD.

Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 19, 2026

BCL11B enhancer hijacking by t(14;16)(q32;q24) translocation defines a novel high-risk subtype of T-ALL.

BCL11B enhancer hijacking by t(14;16)(q32;q24) translocation defines a novel high-risk subtype of T-ALL.

Journal: Blood
Published: September 03, 2025

Development and performance evaluation of a comprehensive genomic profiling assay for hematological malignancies

Development and performance evaluation of a comprehensive genomic profiling assay for hematological malignancies

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 27, 2025

mm2-ivh: simple and precise overlap detection in alpha satellite HORs with interval hashing.

mm2-ivh: simple and precise overlap detection in alpha satellite HORs with interval hashing.

Journal: Bioinformatics (Oxford, England)
Published: July 11, 2025

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies.

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies.

Journal: NPJ precision oncology
Published: June 30, 2025

Age-specific mutation profiles and their prognostic implications in pediatric KMT2A-rearranged acute myeloid leukemia.

Age-specific mutation profiles and their prognostic implications in pediatric KMT2A-rearranged acute myeloid leukemia.

Journal: Haematologica
Published: June 15, 2025

Association of TP53 gain-of-function mutations with early osimertinib resistance in epidermal growth factor receptor-mutant lung adenocarcinoma.

Association of TP53 gain-of-function mutations with early osimertinib resistance in epidermal growth factor receptor-mutant lung adenocarcinoma.

Journal: ESMO open
Published: June 06, 2025

Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancer.

Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancer.

Journal: NPJ breast cancer
Published: May 22, 2025
Showing 1-12 of 220

Last Updated: 09/26/2026